Real-Time Neurofeedback to Modulate β-Band Power in the Subthalamic Nucleus in Parkinson’s Disease Patients
Ryohei Fukuma(The University of Osaka), Haruhiko Kishima(Osaka University Hospital), Fumiaki Yoshida(Suita Municipal Hospital), Satoru Oshino(The University of Osaka), Koichi Hosomi(RELX Group (Netherlands)), Naoki Tani(Osaka Gakuin University), Masataka Tanaka(The University of Osaka), Takufumi Yanagisawa(The University of Osaka)
Cited by 29
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211